Simone U. Dalm

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Head-to-head comparison of [177Lu]Lu-FAP-2286 and [161Tb]Tb-FAP-2286 efficacy in a PDAC mouse model.

Head-to-head comparison of [177Lu]Lu-FAP-2286 and [161Tb]Tb-FAP-2286 efficacy in a PDAC mouse model.

Journal: EJNMMI research

Published: December 01, 2025

Illuminating radionuclide therapy response: Monitoring cancer cell and CAF survival in a direct 2D co-culture model.

Illuminating radionuclide therapy response: Monitoring cancer cell and CAF survival in a direct 2D co-culture model.

Journal: Nuclear medicine and biology

Published: August 08, 2025

Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D.

Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D.

Journal: EJNMMI research

Published: June 23, 2025

N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake.

N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake.

Journal: Journal of medicinal chemistry

Published: March 20, 2025

Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells.

Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells.

Journal: EJNMMI research

Published: February 19, 2025

A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry.

A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 29, 2024

In vitro and ex vivo evaluation of preclinical models for FAP-targeted theranostics: differences and relevance for radiotracer evaluation.

In vitro and ex vivo evaluation of preclinical models for FAP-targeted theranostics: differences and relevance for radiotracer evaluation.

Journal: EJNMMI research

Published: October 09, 2024

Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics.

Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 07, 2024

A Novel Luciferase-Based Reporter Gene Technology for Simultaneous Optical and Radionuclide Imaging of Cells.

A Novel Luciferase-Based Reporter Gene Technology for Simultaneous Optical and Radionuclide Imaging of Cells.

Journal: International journal of molecular sciences

Published: June 13, 2024

In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions.

In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions.

Journal: EJNMMI radiopharmacy and chemistry

Published: June 12, 2024

Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management: Preclinical and Clinical Developments of the Past 5 Years.

Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management: Preclinical and Clinical Developments of the Past 5 Years.

Journal: PET clinics

Published: April 21, 2024

Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice.

Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice.

Journal: Life sciences

Published: August 16, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026